Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × fasudil × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Capecitabine 28 apatinib 25 Cisplatin 24 tislelizumab 23 Oxaliplatin 23 Gemcitabine 23 Irinotecan 19 Paclitaxel 18 Carboplatin 18 Docetaxel 15 Bevacizumab 15 Fluorouracil 13 Drug Therapy 12 Cyclophosphamide 11 pembrolizumab 10 camrelizumab 10 Vinorelbine 9 Radiation 9 S 1 (combination) 8 Cetuximab 8 sintilimab 7 Rituximab 7 Leucovorin 7 Erlotinib Hydrochloride 7 toripalimab 6 pyrotinib 6 Gefitinib 6 Albumin-Bound Paclitaxel 6 fludarabine 5 anlotinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06362707 2024-10-22

FEAD

Helse Stavanger HF

Phase 2 Recruiting

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡